On April 7, 2022 CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported that members of its senior management team are scheduled to participate in the following investor conferences in April (Press release, CRISPR Therapeutics, APR 7, 2022, View Source [SID1234611587]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
21st Annual Needham Virtual Healthcare Conference
Date: Tuesday, April 12, 2022
Time: 12:45 PM ET
Canaccord Genuity Horizons in Oncology Virtual Conference
Date: Thursday, April 14, 2022
Time: 1:00 PM ET
14th Kempen Life Sciences Conference Amsterdam
Date: Wednesday, April 20, 2022
Time: 3:30 PM CET
A live webcast of the Needham presentation will be available on the "Events & Presentations" page in the Investors section of the Company’s website at View Source A replay of the webcasts will be archived on the Company’s website for 14 days following each presentation.